Timing of MRD conversion correlates with MM patient survival. (A) Patients undergoing MRD conversion ≤3 years from ASCT compared with >3 years have an inferior OS (HR, 2.8; 95% CI, 1.8-8.2, P = .0003). (B) Patients undergoing MRD conversion <5 years from ASCT compared with ≥5 years have an inferior OS (HR, 2.1; 95% CI, 1.2-4.0, P = .01). Upper and lower bands represent 95% CI.